With new & emerging targets and drug candidates in immuno-oncology, key opinion leaders from pharmaceutical & biotech companies as well as academic & research organisations will be presenting on innovative approaches & methods for target identification & validation, such as AI-based strategies, novel checkpoint inhibitors and latest developments & case studies in cellular therapies : TILs, gamma deltas, myeloid cells
The event provides an additional 25+ presentations on novel multiplex tools for biomarker analysis, latest cytometry tools & therapeutic applications as well as molecular analysis, multi-cancer early detection and testing, companion diagnostic development and biomarkers for clinical development and personalised patient treatment
Targets & Cell Types in Immuno-Oncology Europe 2023 brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook
Below are the key speakers for our Targets & Cell Types in Immuno-Oncology Europe 2023 event
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of virtual experiences.